DECELLULARIZED GROWTH FACTORS AND CYTOKINES
EV-PURE is a decellularized product consisting of nano-sized micropods containing growth factors, cytokines and nucleic acids secreted from the membranes of placental derived Medicinal Signaling Cells. The natural components in this product support healthy cell-cell communication and provide anti-inflammatory effects.
EV-PURE 7.5 Billion - 0.5mL
EV-PURE 15 Billion - 1mL
EV-PURE 75 Billion - 5mL
20% of every lot manufactured is sent for sterility and endotoxin testing by a 3rd party laboratory. In addition, Vitti Labs requires a Nanocyte Report for each lot and a biannual Characterization Report produced by external laboratories for transparency and validation.
Vitti Labs is an FDA registered tissue bank. We comply with FDA (Federal Drug Administration) regulations. Additionally, we implement AATB (American Association of Tissue Banking) standards, follow GTP (Good Tissue Practices), GMP (Good Manufacturing Guidelines), and WHO (World Health Organization) protocols and procedures.
NS-PURE is a topical extracellular matrix consisting of growth factors, nano sized micropods, collagen elastins, hyaluronan, cytokines, and fibroblasts from amniotic membrane, wharton's jelly, and chorionic villi. NS-PURE has antimicrobial properties and bioactive molecules which stimulate collagen growth, wound healing and promote healthy skin resurfacing.
REGULATIONS: Vitti Labs’ NS-PURE contains live cells but does not claim that it is dependent on the metabolic activity of living cells for its primary function. NS-PURE contains tissue components such as hyaluronan, elastin, collagen fibers, growth factors, cytokines, and nanoparticles which stimulate cushioning agents, therefore, it is not reliant on the presence nor on the metabolism of the cells in this allograft to create a therapeutic benefit. NS-PURE does meet the criteria under 1271.3(d) as an HCT/P, and therefore is regulated under 21 CFR 1271 and Section 361 of the PHS Act.
Vitti Labs is an FDA registered tissue bank. We comply with FDA (Federal Drug Administration) regulations. Additionally, we implement AATB (American Association of Tissue Banking) standards, follow GTP (Good Tissue Practices), GMP (Good Manufacturing Guidelines), and WHO (World Health Organization) protocols and procedures
GeneXSTEM™ is derived from Wharton’s Jelly of the non-embryonic umbilical cord and is intended for homologous use.
GeneXSTEM™ Wharton’s Jelly allograft is shipped overnight frozen directly to your medical practice.
GeneXSTEM Injectables are minimally manipulated human tissue allografts derived from umbilical cord tissue for homologous use. They comply with the HCT/P 21 CFR 1271 Regulations and Section 361 of the Public Health Service Act.
Magellan PRP / cBMA Prep System: Safety : Efficacy : Efficiency : Affordability
Safety/Efficiency: Fully enclosed, 100% automated processing system with no human intervention or environmental exposure.
Efficacy: Most efficient end-product concentrations on the market (up to 14x over baseline for both PRP and cBMA).
* Preferred vendor for Hospital GPO's and IDN's nationwide
Affordability: Boasts the ONLY disposable kit that is FDA Approved to be re-used up to 3x on the same patient.
We provide a full turnkey solution to successfully implement Bioidentical Hormone Replacement Therapy into your Practice, Clinic, or Med Spa. Our program consists of three core components: Training and Education, Dosing and Prescribing and Marketing to your existing as well as external patients.